ANUHPHRNSEAnuh Pharma LimitedMediumNeutral
Announced Fri, 22 Aug · 18:36 IST

Anuh Pharma Limited has informed the Exchange regarding Proceedings of 65th Annual General Meeting held on August 22, 2025

Board & Shareholder Meetings View source PDF

ANUHPHR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Anuh Pharma held its 65th AGM on August 22, 2025, from 4:00 PM to 4:45 PM in Mumbai, attended by 40 members in person with 12 directors present. All 10 resolutions were passed, including adoption of the audited financial statements for FY 2024-25 and declaration of a dividend of Rs. 1.50 per equity share (face value Rs. 5). Members approved the re-appointment of two retiring directors, ratification of the cost auditor, and appointment of a new secretarial auditor for five years (FY 2025-26 to FY 2029-30). Both Joint Managing Directors, Mr. Ritesh Shah and Mr. Vivek Shah, received a revision in remuneration for FY 2025-26 and were re-appointed for a fresh 5-year term from January 8, 2026 to January 7, 2031. Voting combined remote e-voting (August 19-21) with a poll at the meeting, with results to be submitted to the exchanges within two working days.

Likely market impact

Investors will receive a Rs. 1.50 per share dividend for FY25, while continuity in leadership with the re-appointment of both Joint MDs signals stability, though the upward revision in their pay may marginally lift administrative expenses in FY26.